Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cross Pacific Pharma Connect AB
AB
Active
Org 5594778655
Husarvägen 36, 194 49
Upplands Väsby
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2024
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cross Pacific Pharma Connect AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
0
Staff expenses
—
EBITDA
−175
Depreciation & amort.
−0
EBIT
−175
Net financials
—
Profit before tax
−175
Tax
−0
Net profit
−175
Balance sheet
SEK thousands
Item
2024
Total assets
35
Equity
35
Long-term debt
0
Short-term debt
0
Total debt
—
Financial ratios
5-year trend
EBITDA margin
-17500000.0%
This company
15.8%
Market median
-110759594% vs market
2024
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2024
2024
Return on equity
-500.0%
This company
18.4%
Market median
-2817% vs market
2024
2024
Net profit margin
-17500000.0%
This company
8.1%
Market median
-216049483% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-03-01 – 2024-12-31
View
PDF
More on Cross Pacific Pharma Connect AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
